Therapeutic Drug Monitoring of Oral Voriconazole in an Infant Less than Six Months of Age and Pharmacokinetics Changes Induced by Development of CYP2C19 in the Growth Process: A No... von Yamaguchi, Atsushi, Tazawa, Yuki, Ueki, Masashiro, Yamada, Masafumi, Manabe, Atsushi, Sugawara, Mitsuru, Takekuma, Yoh

Volltext

Schedule-Dependent Cytotoxicity of Etoposide and Cyclophosphamide in P-Glycoprotein-Expressing Human Leukemic K-562 Cells von Tazawa, Yuki, Usukubo, Ippei, Takada, Kazuki, Takekuma, Yoh, Shibayama, Yoshihiro, Sugawara, Mitsuru

Volltext

Necessity for a Significant Maintenance Dosage Reduction of Voriconazole in Patients with Severe Liver Cirrhosis (Child - Pugh Class C) von Takehiro Yamadaa, Shungo Imaia, Yasuyuki Koshizukab, Yuki Tazawaa, Keisuke Kagamia, Naoki Tomiyamaa, Ryosuke Sugawaraa, Akira Yamagamia, Tsuyoshi Shimamurac, Ken Isekia, d

Volltext

Possibility of Poor Outcomes after Treatment Using Teicoplanin at the Minimum Inhibitory Concentration of >2 μg/mL in Methicillin-resistant Staphylococcus aureus Bacteremia von Kagami, Keisuke, Imai, Shungo, Tazawa, Yuki, Iwasaki, Sumio, Fukumoto, Tatsuya, Akizawa, Koji, Yamada, Takehiro, Ishiguro, Nobuhisa, Iseki, Ken

Volltext